AzTrials
AzTrials

Temporomandibular Disorders (TMD)Phase 3NCT07018791

Art-Based Pain Assessment Tool in Patients With Temporomandibular Joint Disorders

A Phase 3 study testing Standard TMD Assessment and Artistic Pain Exploration (APE) Method in people with Temporomandibular Disorders (TMD) and Wilkes 1 and 2, run by King Abdulaziz University at 1 site in Saudi Arabia.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Title of Study: Assessment of the Impact of Art-Based Pain Assessment Tool on Pain Communication, Joint Function, and Anxiety in Patients with Temporomandibular Disorders (TMD): A Randomized Controlled Trial Location: King Abdulaziz University Dental Hospital (KAUFD), Jeddah, Saudi Arabia What Is This Study About?… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Standard TMD Assessment and Artistic Pain Exploration (APE) Method
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteSaudi Arabia
Study dates
25 Apr 2025to 30 Oct 2025
Phase
Phase 3
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adults aged 18 years or older
  • Diagnosed with Temporomandibular Disorders (TMD) requiring conservative management only and classified as Wilkes' stage I or II
  • Able to understand and sign the informed consent form

Who cannot join

  • Patients requiring surgical intervention for TMD
  • Presence of severe mental illness, such as psychotic disorders or bipolar affective disorders
  • Regular use of narcotic (opioid) pain medications

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Razan M Baabdullah, BDS, MS, FRCDC contact

+96655501567

rmsbaabdullah@kau.edu.sa

Saudi Arabia1 site, 1 recruiting
  • King Abdulaziz University, Faculty of Dentistry

    Jeddah, Mecca Region

    Haneen Shaaban, MSc, +966126400000, den-rec@kau.edu.sa

    Recruiting

Other trials in Saudi Arabia

About this study

Official title: Assessment of the Impact of Art-Based Pain Assessment Tool on Pain Communication, Joint Function, and Anxiety in Patients With Temporomandibular Joint Disorders: A Randomized Controlled Trial

Title of Study:

Assessment of the Impact of Art-Based Pain Assessment Tool on Pain Communication, Joint Function, and Anxiety in Patients with Temporomandibular Disorders (TMD): A Randomized Controlled Trial

Read more

Location:

King Abdulaziz University Dental Hospital (KAUFD), Jeddah, Saudi Arabia What Is This Study About?

This study examines how an art-based tool can help improve communication and understanding of pain among patients with jaw joint disorders (TMD). It compares two groups:

  • Standard care: Routine diagnostic and therapeutic procedures
  • Intervention: Standard care plus a guided art-based tool using paintings to express and discuss the TMD experiences What Is the Art-Based Tool?

This novel method, called the Artistic Pain Exploration (APE), uses paintings to help patients describe their pain that relates to TMD and its effect on their quality of life:

  1. Participants will be shown three paintings (e.g., The Scream by Edvard Munch)
  2. Participants will choose the one that best resonates with them
  3. A guided discussion follows, exploring how the image relates to their physical and emotional pain as well as the effect of pain on their daily activities

Research Questions:

  1. Does using the APE method help participants better communicate and understand their pain?
  2. Does it improve jaw function and reduce anxiety more than standard assessment? Who Can Participate?

Participants may be eligible if they:

  • Are 18 years or older
  • Have early-stage TMD (not needing surgery)
  • Can give informed consent

Participants cannot participate if they:

  • Require jaw surgery
  • Have severe mental illness (e.g., psychosis or bipolar disorder)
  • Take narcotic pain medications regularly What Will Happen During the Study?
  • Participants are randomly assigned to one of the two groups.
  • Each participant will complete a standardized questionnaire before and after two weeks to assess the level of anxiety.
  • All participants will be screened for depression via a standardized questionnaire before the first visit.
  • All will undergo a clinical exam to assess the TMJ pain and function and receive appropriate medications and lifestyle instructions.
  • Some participants (intervention group) will also discuss their pain using the artwork.
  • All participants will be seen for a follow up in 2 weeks to assess the TMJ function and pain.

Potential Risks and Discomforts

Participants may experience:

  • Emotional discomfort while discussing pain
  • Mild anxiety during interviews or questionnaires If needed, a psychiatrist on the research team will provide support or referrals.

Potential Benefits

  • A better understanding of pain
  • Improved communication with care provider
  • Possible improvement in pain and jaw function

Costs There are no costs to participate. All treatments are provided free of charge.

Compensation / Treatment for Injury

  • If participants experience harm from this study, necessary medical care will be provided by the research team.
  • No financial compensation will be provided by King Abdulaziz University.

Confidentiality Participants' identity and medical records will remain confidential. Only approved researchers and auditors will have access to data, in accordance with applicable laws. Any results published will not include participants' name or identifying details.

Being tested
Standard TMD Assessment, Artistic Pain Exploration (APE) Method
Keywords
Temporomandibular joint disorders, Artistic Pain Exploration (APE), Visual Pain Expression, Art-Based Assessment, Multisensory Pain Assessment, Randomized Controlled Trial, Pain Communication, Patient-Reported Outcomes, TMJ Function
Medical subject headings
Temporomandibular Joint Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard TMD AssessmentDiagnostic test

    This is the conventional diagnostic and management approach for TMD, focusing on physical evaluation and symptom tracking without the use of any visual or art-based tools. It serves as the baseline for comparison in this study.

  • Artistic Pain Exploration (APE) MethodDiagnostic test

    Also called Art-based assessment tool

    This approach involves showing patients three expressive paintings and asking them to select the one that best resonates with them. A guided interview follows, using the artwork to explore the patient's pain characteristics, emotional impact, and functional limitations. This method aims to provide a richer, more personalized understanding of the patient's pain experience.

Study groups in NCT07018791
Study groupRoleWhat they receive
Control GroupActive comparatorParticipants in this group receive standard care for Temporomandibular Joint Disorders (TMD), which includes a clinical examination, assessment of pain using the Visual Analogue Scale (VAS), anxiety and depression screening (GAD-7 and PHQ-9), evaluation of jaw pain and function, and conservative treatment through medication and self-care instructions.
Receives: Diagnostic Test: Standard TMD Assessment
Intervention GroupExperimentalParticipants in this group receive the same standard care as the control group, with the addition of an art-based method designed to enhance the understanding and communication of pain.
Receives: Diagnostic Test: Standard TMD Assessment; Diagnostic Test: Artistic Pain Exploration (APE) Method

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient-reported outcomes on pain understanding and communication

    The Pain Communication and Understanding Questionnaire is a validated tool designed to assess how well patients understand their own pain and how effectively they are able to communicate that experience with their healthcare provider.

    Measured: Baseline

Secondary outcomes (4)
  1. Pain Level

    Measured by the Visual Analogue Scale (VAS), this outcome captures the intensity of pain as reported by the patient on a scale from 0 (no pain) to 10 (worst pain imaginable).

    Measured: At baseline and 2-week follow-up.

  2. Temporomandibular Joint (TMJ) Function

    TMJ functional capacity will be evaluated through a set of clinical assessments:

    Maximal interincisal distance (mm): measured as the maximum unassisted vertical opening between the incisal edges of upper and lower central incisors using a calibrated ruler or caliper.

    Mandibular excursive and protrusive movements (mm): lateral and anterior movements will be measured from centric occlusion to maximum displacement.

    Pain on mouth opening (VAS 0-10): Participants will rate pain intensity during maximum mouth opening using a 10-point visual analog scale.

    Presence of joint sounds (clicking/crepitus): assessed through bilateral palpation and auscultation during mandibular motion; recorded as Present or Absent.

    Presence of occlusal wear facets: identified through intraoral examination; recorded as Present or Absent.

    Muscle of mastication tenderness: evaluated via bilateral palpation of the muscles of mastication and recorded as tender or non-tender.

    Measured: At baseline and 2-week follow-up.

  3. Anxiety level

    Assessed using the General Anxiety Disorder-7 (GAD-7) questionnaire, this outcome indicates the severity of anxiety symptoms experienced by the patient. The minimum score is zero and the maximum is 21. Lower scores mean lower anxiety levels.

    Measured: At baseline and 2-week follow-up

  4. Depression Screening

    Screened at baseline using the Patient Health Questionnaire-9 (PHQ-9), this outcome identifies the presence and severity of depressive symptoms in the patient. The minimum score is zero and the maximum is 27. Lower PHQ-9 scores indicate fewer or less severe depressive symptoms.

    Measured: At baseline only.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2025
  2. Study start25 Apr 2025
  3. Primary completion30 Oct 2025 (estimated)
  4. Study completion30 Oct 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07018791
Sponsor's protocol ID
02-01-25
Status last verified
Jun 2025
First submitted
4 Jun 2025
Last updated
15 Jun 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Al-Khotani A, Naimi-Akbar A, Gjelset M, Albadawi E, Bello L, Hedenberg-Magnusson B, Christidis N. The associations between psychosocial aspects and TMD-pain related aspects in children and adolescents. J Headache Pain. 2016;17:30. doi: 10.1186/s10194-016-0622-0. Epub 2016 Apr 5.

    PubMed 27044436
  • Wilson C, Bungay H, Munn-Giddings C, Boyce M. Healthcare professionals' perceptions of the value and impact of the arts in healthcare settings: A critical review of the literature. Int J Nurs Stud. 2016 Apr;56:90-101. doi: 10.1016/j.ijnurstu.2015.11.003. Epub 2015 Nov 27.

    PubMed 26696399
  • Regev D, Cohen-Yatziv L. Effectiveness of Art Therapy With Adult Clients in 2018-What Progress Has Been Made? Front Psychol. 2018 Aug 29;9:1531. doi: 10.3389/fpsyg.2018.01531. eCollection 2018.

    PubMed 30210388
  • Kirkham JA, Smith JA, Havsteen-Franklin D. Painting pain: an interpretative phenomenological analysis of representations of living with chronic pain. Health Psychol. 2015 Apr;34(4):398-406. doi: 10.1037/hea0000139.

    PubMed 25822055

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Standard TMD Assessment and Artistic Pain Exploration (APE) Method in people with Temporomandibular Disorders (TMD) and Wilkes 1 and 2, run by King Abdulaziz University at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Razan M Baabdullah, BDS, MS, FRCDC (+96655501567, rmsbaabdullah@kau.edu.sa), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient-reported outcomes on pain understanding and communication (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07018791, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in